{"id":7985,"date":"2018-11-22T09:29:41","date_gmt":"2018-11-22T14:29:41","guid":{"rendered":"https:\/\/themedicalxchange.com\/?p=7985"},"modified":"2021-07-20T10:02:08","modified_gmt":"2021-07-20T14:02:08","slug":"aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison","status":"publish","type":"post","link":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/","title":{"rendered":"Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison"},"content":{"rendered":"<p>La possibilit\u00e9 d\u2019arr\u00eater le traitement chez les patients totalement r\u00e9tablis n\u2019avait encore jamais fait l\u2019objet d\u2019une \u00e9tude \u00e0 r\u00e9partition al\u00e9atoire, mais cet essai, appel\u00e9 TRED-HF, fournit des donn\u00e9es qui vont \u00e0 l\u2019encontre d\u2019une telle strat\u00e9gie, selon le D<sup>r<\/sup>\u00a0Brian Halliday, chercheur principal et charg\u00e9 de cours-clinicien en cardiologie \u00e0 l\u2019Imperial College, \u00e0 Londres, au Royaume-Uni. Ces donn\u00e9es tendent \u00e0 d\u00e9montrer qu\u2019une \u00ab&nbsp;am\u00e9lioration du fonctionnement constitue une r\u00e9mission plut\u00f4t qu\u2019une gu\u00e9rison durable pour de nombreux patients.&nbsp;\u00bb<\/p>\n<p>M\u00eame s\u2019il s\u2019agissait d\u2019un essai pilote men\u00e9 dans un seul centre, des patients ayant des ant\u00e9c\u00e9dents de cardiomyopathie dilat\u00e9e (FEVG &lt; 40 % au moment du diagnostic) recrut\u00e9s pour TRED-HF n\u2019y \u00e9taient admissibles que s\u2019ils semblaient avoir obtenu un r\u00e9tablissement complet. Les crit\u00e8res d\u2019admission \u00e9taient une FEVG &gt; 50 %, un indice de volume t\u00e9l\u00e9diastolique du ventricule gauche (iVTDVG) normal et un taux de peptide natriur\u00e9tique de type B N-terminal (NT-proBNP) &lt; 250 ng\/L. Les patients devaient aussi \u00eatre asymptomatiques (classe I de la NYHA).<\/p>\n<p>Parmi les 51 patients inscrits, 25 ont \u00e9t\u00e9 affect\u00e9s au hasard \u00e0 un programme de retrait graduel et 26, \u00e0 la poursuite du traitement. \u00c0 des intervalles de trois semaines, sous surveillance, les patients recevant un traitement standard ont cess\u00e9 successivement de prendre leurs diur\u00e9tiques, leurs antagonistes des r\u00e9cepteurs des min\u00e9ralocortico\u00efdes, leurs b\u00eatabloquants puis leurs inhibiteurs de l\u2019enzyme de conversion de l\u2019angiotensine (ECA) ou leurs antagonistes des r\u00e9cepteurs de l\u2019angiotensine. Une \u00e9valuation clinique \u00e9tait effectu\u00e9e apr\u00e8s chaque retrait.<\/p>\n<p>Le param\u00e8tre d\u2019\u00e9valuation principal \u00e9tait l\u2019atteinte de l\u2019un des signes de r\u00e9cidive, d\u00e9finis comme une r\u00e9duction de la FEVG de plus de 10 %, une augmentation de l\u2019iVTDVG de plus de 10 %, un taux de NT-pro-BNP qui doublait ou d\u00e9passait 400 ng\/L et des signes cliniques d\u2019insuffisance cardiaque. La comparaison des deux groupes le 6e mois a r\u00e9v\u00e9l\u00e9 que les patients ayant continu\u00e9 leur traitement pouvaient passer au protocole de retrait graduel au terme de cette p\u00e9riode <a href=\"javascript:void(0)\" class=\"show-image\" data-index=\"0\">(Fig. 1)<\/a>.<\/p>\n<p>Apr\u00e8s 6 mois, 11 (44 %) des 25 patients ayant cess\u00e9 leur traitement avaient pr\u00e9sent\u00e9 un signe de r\u00e9cidive d\u00e9fini comme param\u00e8tre d\u2019\u00e9valuation principal, contre aucun dans le groupe ayant continu\u00e9 le traitement. Des 26 patients affect\u00e9s initialement \u00e0 la poursuite du traitement, 25 ont opt\u00e9 pour une tentative de retrait. Dans les 6 mois suivants, 9 (36 %) d\u2019entre eux ont connu une r\u00e9cidive.\u00a0<\/p>\n<p>Dans les deux groupes, \u00ab&nbsp;un suivi plus long se serait probablement traduit par des taux encore plus \u00e9lev\u00e9s de r\u00e9cidive&nbsp;\u00bb, dit le D<sup>r<\/sup> Halliday. Il souligne que l\u2019effet moyen estimatif du retrait sur certaines mesures de l\u2019insuffisance cardiaque, dont la FEVG (\u22129,5 %; <em>p<\/em> = 0,0001), par rapport aux valeurs initiales a \u00e9t\u00e9 tr\u00e8s statistiquement significatif. Bien qu\u2019il n\u2019y ait pas eu d\u2019hospitalisations impr\u00e9vues pour une insuffisance cardiaque, de manifestations cardiaques ind\u00e9sirables majeures ni d\u2019arythmies ventriculaires pendant le suivi, 3 patients ont pr\u00e9sent\u00e9 une fibrillation auriculaire apr\u00e8s l\u2019arr\u00eat du traitement.<\/p>\n<p>Beaucoup de patients qui se sentent bien et ont une fonction de pompage normale apr\u00e8s une cardiomyopathie dilat\u00e9e demandent d\u2019arr\u00eater leur traitement, ajoute le Dr Halliday. Toutefois, avant cet essai, il n\u2019existait pas de donn\u00e9es prospectives pour d\u00e9terminer si l\u2019arr\u00eat du traitement \u00e9tait ou non une strat\u00e9gie s\u00fbre. Le D<sup>r<\/sup>\u00a0Halliday en conclut qu\u2019il faut d\u00e9conseiller \u00e0 tous ces patients de cesser leur traitement \u00e0 ce moment-l\u00e0. Chez ceux qui insistent, \u00ab&nbsp;un solide plan de surveillance doit \u00eatre mis en place&nbsp;\u00bb \u00e0 la lumi\u00e8re de ces donn\u00e9es montrant qu\u2019une r\u00e9cidive est fr\u00e9quente.<\/p>\n<p>Une experte invit\u00e9e par l\u2019AHA \u00e0 discuter des r\u00e9sultats abonde dans le m\u00eame sens. Selon la D<sup>re<\/sup>\u00a0Jane E. Wilcox, cardiologue \u00e0 la Northwestern Feinberg School of Medicine \u00e0 Chicago, en Illinois, les r\u00e9sultats de cette \u00e9tude relativement de petite envergure ne peuvent \u00eatre consid\u00e9r\u00e9s comme \u00e9tant d\u00e9finitifs, mais sont certainement des arguments \u00ab&nbsp;\u00e0 l\u2019appui du maintien sans interruption d\u2019un traitement pour l\u2019insuffisance cardiaque&nbsp;\u00bb m\u00eame chez les patients qui se portent bien.<\/p>\n<h2>Conclusion<\/h2>\n<p>\u00ab&nbsp;En 2018, nous sommes incapables de reconna\u00eetre une gu\u00e9rison r\u00e9elle, si tel est le cas. R\u00e9mission est un terme appropri\u00e9 pour les patients assez chanceux pour avoir une fonction ventriculaire am\u00e9lior\u00e9e en r\u00e9ponse au traitement&nbsp;\u00bb, dit la D<sup>re<\/sup>\u00a0Wilcox. \u00c0 l\u2019instar du D<sup>r<\/sup>\u00a0Halliday, elle avance qu\u2019il pourrait y avoir un sous-groupe qui peut abandonner le traitement sans risque, mais ce sous-groupe n\u2019est pas pr\u00e9cis\u00e9.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><b> Chicago <\/b> &#8211; Le traitement pour une cardiomyopathie dilat\u00e9e doit \u00eatre poursuivi ind\u00e9finiment m\u00eame chez les patients qui semblent totalement r\u00e9tablis, d\u2019apr\u00e8s les r\u00e9sultats d\u2019un essai \u00e0 r\u00e9partition al\u00e9atoire. Les r\u00e9sultats de derni\u00e8re minute pr\u00e9sent\u00e9s aux s\u00e9ances scientifiques 2018 de l\u2019American Heart Association (AHA) indiquent que seulement 44 % des patients ont pu cesser compl\u00e8tement leur traitement de l\u2019insuffisance cardiaque pendant une p\u00e9riode de 6 mois sans d\u00e9t\u00e9rioration de la fraction d\u2019\u00e9jection ventriculaire gauche (FEVG) ni apparition d\u2019autres signes de r\u00e9cidive.<\/p>\n","protected":false},"author":9,"featured_media":7986,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"tags":[522,511,425,301,523],"class_list":["post-7985","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-2018-fr","tag-aha-fr-2","tag-aha-fr","tag-cardiologie","tag-extract-fr","area_tag-cardiologie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison - The Medical Xchange<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison - The Medical Xchange\" \/>\n<meta property=\"og:description\" content=\"Chicago - Le traitement pour une cardiomyopathie dilat\u00e9e doit \u00eatre poursuivi ind\u00e9finiment m\u00eame chez les patients qui semblent totalement r\u00e9tablis, d\u2019apr\u00e8s les r\u00e9sultats d\u2019un essai \u00e0 r\u00e9partition al\u00e9atoire. Les r\u00e9sultats de derni\u00e8re minute pr\u00e9sent\u00e9s aux s\u00e9ances scientifiques 2018 de l\u2019American Heart Association (AHA) indiquent que seulement 44 % des patients ont pu cesser compl\u00e8tement leur traitement de l\u2019insuffisance cardiaque pendant une p\u00e9riode de 6 mois sans d\u00e9t\u00e9rioration de la fraction d\u2019\u00e9jection ventriculaire gauche (FEVG) ni apparition d\u2019autres signes de r\u00e9cidive.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/\" \/>\n<meta property=\"og:site_name\" content=\"The Medical Xchange\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-22T14:29:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-20T14:02:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/American_Heart_Association_AHA_2018_TRED-HF_7020_Figure_1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Daniela Lopes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daniela Lopes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/\"},\"author\":{\"name\":\"Daniela Lopes\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/f3318b53ccceaeb046bcb26e99f5c94c\"},\"headline\":\"Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison\",\"datePublished\":\"2018-11-22T14:29:41+00:00\",\"dateModified\":\"2021-07-20T14:02:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/\"},\"wordCount\":809,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/American_Heart_Association_AHA_2018_TRED-HF_7020_Figure_1.png\",\"keywords\":[\"2018\",\"AHA\",\"AHA\",\"cardiologie\",\"extract\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/\",\"name\":\"Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison - The Medical Xchange\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/American_Heart_Association_AHA_2018_TRED-HF_7020_Figure_1.png\",\"datePublished\":\"2018-11-22T14:29:41+00:00\",\"dateModified\":\"2021-07-20T14:02:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/f3318b53ccceaeb046bcb26e99f5c94c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/#primaryimage\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/American_Heart_Association_AHA_2018_TRED-HF_7020_Figure_1.png\",\"contentUrl\":\"https:\\\/\\\/themedicalxchange.com\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/American_Heart_Association_AHA_2018_TRED-HF_7020_Figure_1.png\",\"width\":960,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/2018\\\/11\\\/22\\\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/\",\"name\":\"The Medical Xchange\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/themedicalxchange.com\\\/en\\\/#\\\/schema\\\/person\\\/f3318b53ccceaeb046bcb26e99f5c94c\",\"name\":\"Daniela Lopes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g\",\"caption\":\"Daniela Lopes\"},\"url\":\"https:\\\/\\\/themedicalxchange.com\\\/fr\\\/author\\\/daniela\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison - The Medical Xchange","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/","og_locale":"fr_FR","og_type":"article","og_title":"Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison - The Medical Xchange","og_description":"Chicago - Le traitement pour une cardiomyopathie dilat\u00e9e doit \u00eatre poursuivi ind\u00e9finiment m\u00eame chez les patients qui semblent totalement r\u00e9tablis, d\u2019apr\u00e8s les r\u00e9sultats d\u2019un essai \u00e0 r\u00e9partition al\u00e9atoire. Les r\u00e9sultats de derni\u00e8re minute pr\u00e9sent\u00e9s aux s\u00e9ances scientifiques 2018 de l\u2019American Heart Association (AHA) indiquent que seulement 44 % des patients ont pu cesser compl\u00e8tement leur traitement de l\u2019insuffisance cardiaque pendant une p\u00e9riode de 6 mois sans d\u00e9t\u00e9rioration de la fraction d\u2019\u00e9jection ventriculaire gauche (FEVG) ni apparition d\u2019autres signes de r\u00e9cidive.","og_url":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/","og_site_name":"The Medical Xchange","article_published_time":"2018-11-22T14:29:41+00:00","article_modified_time":"2021-07-20T14:02:08+00:00","og_image":[{"width":960,"height":720,"url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/American_Heart_Association_AHA_2018_TRED-HF_7020_Figure_1.png","type":"image\/png"}],"author":"Daniela Lopes","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Daniela Lopes","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/#article","isPartOf":{"@id":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/"},"author":{"name":"Daniela Lopes","@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/f3318b53ccceaeb046bcb26e99f5c94c"},"headline":"Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison","datePublished":"2018-11-22T14:29:41+00:00","dateModified":"2021-07-20T14:02:08+00:00","mainEntityOfPage":{"@id":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/"},"wordCount":809,"commentCount":0,"image":{"@id":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/#primaryimage"},"thumbnailUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/American_Heart_Association_AHA_2018_TRED-HF_7020_Figure_1.png","keywords":["2018","AHA","AHA","cardiologie","extract"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/","url":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/","name":"Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison - The Medical Xchange","isPartOf":{"@id":"https:\/\/themedicalxchange.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/#primaryimage"},"image":{"@id":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/#primaryimage"},"thumbnailUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/American_Heart_Association_AHA_2018_TRED-HF_7020_Figure_1.png","datePublished":"2018-11-22T14:29:41+00:00","dateModified":"2021-07-20T14:02:08+00:00","author":{"@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/f3318b53ccceaeb046bcb26e99f5c94c"},"breadcrumb":{"@id":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/#primaryimage","url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/American_Heart_Association_AHA_2018_TRED-HF_7020_Figure_1.png","contentUrl":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2018\/11\/American_Heart_Association_AHA_2018_TRED-HF_7020_Figure_1.png","width":960,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/themedicalxchange.com\/fr\/2018\/11\/22\/aha_7020_un-essai-recent-montre-que-le-retablissement-dune-insuffisance-cardiaque-est-une-remission-et-non-une-guerison\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/themedicalxchange.com\/en\/"},{"@type":"ListItem","position":2,"name":"Un essai r\u00e9cent montre que le r\u00e9tablissement d\u2019une insuffisance cardiaque est une r\u00e9mission et non une gu\u00e9rison"}]},{"@type":"WebSite","@id":"https:\/\/themedicalxchange.com\/en\/#website","url":"https:\/\/themedicalxchange.com\/en\/","name":"The Medical Xchange","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/themedicalxchange.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/themedicalxchange.com\/en\/#\/schema\/person\/f3318b53ccceaeb046bcb26e99f5c94c","name":"Daniela Lopes","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a4d4340f72c70805b8fc092df1dd86431200950aa59bad0988855570fdf53af5?s=96&d=mm&r=g","caption":"Daniela Lopes"},"url":"https:\/\/themedicalxchange.com\/fr\/author\/daniela\/"}]}},"_links":{"self":[{"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/posts\/7985","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/comments?post=7985"}],"version-history":[{"count":0,"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/posts\/7985\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/media\/7986"}],"wp:attachment":[{"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/media?parent=7985"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/themedicalxchange.com\/fr\/wp-json\/wp\/v2\/tags?post=7985"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}